SCHEMBL7645833

SCHEMBL7645833

O=C(NC1CC1)c1ccc(F)c(F)c1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.55
ADRA2A P08913 1/20 0.54
MCHR1 Q99705 1/20 0.54
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
EPHX2 P34913 3/20 0.50
KDM1A O60341 1/20 0.47
MAOA P21397 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
P2RX7 Q99572 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TAS1R3 Q7RTX0 2/20 0.44
TAS1R1 Q7RTX1 2/20 0.44
TAS1R2 Q8TE23 2/20 0.44
POLB P06746 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7647584 0.93 EPHX2 (0.55) HPGDADRA2AMCHR1CES2CES1
SCHEMBL7647879 0.93 EPHX2 (0.59) HPGDADRA2AMCHR1CES2CES1
SCHEMBL3170903 0.84 P2RX7 (0.57) HPGDCES2CES1NPC1RAB9A
SCHEMBL25690510 0.83 HPGD (0.53) HPGDADRA2AMCHR1KDM1AMAOA
SCHEMBL10639906 0.82 CES2 (0.44) HPGDADRA2AMCHR1CES2CES1
SCHEMBL19947326 0.78 HPGD (0.63) HPGDNPC1RAB9ASMN1; SMN2P2RX7
SCHEMBL4191547 0.77 HPGD (0.71) HPGDCES2CES1NPC1RAB9A
SCHEMBL363351 0.76 NPC1 (0.60) HPGDMCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL15228881 0.76 HPGD (0.49) HPGDKDM1AMAOANPC1RAB9A
SCHEMBL5488770 0.76 HPGD (0.49) HPGDNPC1RAB9AP2RX7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486349-B1 Amide therapeutics and methods for treating inflammatory bowel disease CENTAUR PHARMACEUTICALS, INC. 2002-11-26 US claimed
WO-2001035950-A2 BENZAMIDE THERAPEUTICS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-05-25 WO claimed
US-6486349-B1 Amide therapeutics and methods for treating inflammatory bowel disease CENTAUR PHARMACEUTICALS, INC. 2002-11-26 US disclosed
WO-2001035950-A2 BENZAMIDE THERAPEUTICS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-05-25 WO disclosed